| Trial (first author, year of publication) | Experimental | Control | Weight (%) | Risk ratio | Events | Total | Events | Total | M-H, fixed, 95% CI |
| (A) Trials calculating the total effectiveness rate according to the NP formula |
| (1) Fire needle therapy + 308-nm excimer laser versus 308-nm excimer laser alone | Chen S. Y, 2018 | 11 | 20 | 5 | 20 | 0.70 | 2.20 [0.93, 5.18] | Dun G, 2016 | 46 | 50 | 34 | 50 | 4.50 | 1.35 [1.10, 1.66] | Gu T, 2018 | 41 | 52 | 26 | 52 | 3.40 | 1.58 [1.16, 2.14] | Jiang M. J, 2016 | 23 | 30 | 15 | 30 | 2.00 | 1.53 [1.02, 2.31] | Kuang W. B, 2013 | 76 | 96 | 44 | 90 | 6.00 | 1.62 [1.28, 2.05] | Ren L. S, 2016 | 42 | 50 | 33 | 50 | 4.40 | 1.27 [1.01, 1.61] | Xu C. Q, 2018 | 35 | 40 | 20 | 40 | 2.60 | 1.75 [1.26, 2.44] | Yu C. D, 2017 | 23 | 30 | 17 | 28 | 2.30 | 1.26 [0.88, 1.81] | Zhu Y. Y, 2016 | 36 | 43 | 28 | 40 | 3.80 | 1.20 [0.94, 1.52] | Subtotal (95% CI) | | 411 | | 400 | 29.80 | 1.46 [1.32, 1.61] | Total events | 333 | | 222 | | | | Heterogeneity: Chi2 = 8.17, df = 8 ; I2 = 2% | Test for overall effect: Z = 7.56 |
| (2) Fire needle therapy + other TCM methods versus other TCM methods alone | Bo Z. F, 2017 | 12 | 23 | 3 | 23 | 0.40 | 4.00 [1.30, 12.33] | Fu F, 2019 | 18 | 30 | 8 | 30 | 1.10 | 2.25 [1.16, 4.36] | Lin M, 2019 | 31 | 48 | 15 | 47 | 2.00 | 2.02 [1.27, 3.23] | Liu Z. H, 2019 | 45 | 60 | 34 | 60 | 4.50 | 1.32 [1.02, 1.73] | Xu D. P, 2016 | 20 | 29 | 11 | 29 | 1.50 | 1.82 [1.07, 3.08] | Yang D. K, 2014 | 21 | 30 | 12 | 29 | 1.60 | 1.69 [1.03, 2.77] | Zhao X, 2018 | 35 | 49 | 27 | 49 | 3.60 | 1.30 [0.95, 1.76] | Zhao Y, 2015 | 27 | 39 | 15 | 39 | 2.00 | 1.80 [1.15, 2.82] | Subtotal (95% CI) | | 308 | | 306 | 16.60 | 1.66 [1.43, 1.94] | Total events | 209 | | 125 | | | | Heterogeneity: Chi2 = 9.39, df = 7 ; I2 = 25% | Test for overall effect: Z = 6.51 |
| (3) fire needle therapy + tacrolimus ointment versus tacrolimus ointment alone | Xia F, 2019 | 20 | 24 | 13 | 23 | 1.80 | 1.47 [0.99, 2.20] | Yang D, 2017 | 20 | 31 | 13 | 31 | 1.70 | 1.54 [0.94, 2.51] | Yang M, 2017 | 6 | 18 | 3 | 19 | 0.40 | 2.11 [0.62, 7.20] | Subtotal (95% CI) | | 73 | | 73 | 3.90 | 1.57 [1.15, 2.14] | Total events | 46 | | 29 | | | | Heterogeneity: Chi2 = 0.32, df = 2 ; I2 = 0% | Test for overall effect: Z = 2.81 |
| (4) Fire needle therapy + other treatments versus other treatments alone | Chen G. F, 2017 | 20 | 27 | 9 | 26 | 1.20 | 2.14 [1.21, 3.80] | Chen X, 2018 | 9 | 33 | 12 | 36 | 1.50 | 0.82 [0.40, 1.69] | Dang C, 2019 | 15 | 20 | 9 | 20 | 1.20 | 1.67 [0.96, 2.88] | Du Y. S, 2019 | 19 | 40 | 15 | 38 | 2.00 | 1.20 [0.72, 2.01] | Liu X, 2018 | 29 | 45 | 17 | 40 | 2.40 | 1.52 [1.00, 2.31] | Mai L. X, 2017 | 20 | 31 | 5 | 23 | 0.80 | 2.97 [1.31, 6.73] | Reng S. S, 2018 | 22 | 24 | 16 | 24 | 2.10 | 1.38 [1.01, 1.87] | Tian L. Y, 2018 | 22 | 40 | 13 | 40 | 1.70 | 1.69 [1.00, 2.87] | Wang W. L, 2017 | 29 | 39 | 16 | 39 | 2.10 | 1.81 [1.19, 2.76] | Wang W. L, 2018 | 45 | 50 | 32 | 50 | 4.20 | 1.41 [1.12, 1.77] | Yin Y. Q, 2018 | 18 | 32 | 10 | 31 | 1.30 | 1.74 [0.96, 3.16] | Zhang F. R, 2018 | 17 | 34 | 13 | 33 | 1.70 | 1.27 [0.74, 2.18] | Zhao X. M, 2019 | 29 | 45 | 20 | 45 | 2.60 | 1.45 [0.98, 2.15] | Zhou R. X, 2012 | 68 | 100 | 40 | 100 | 5.30 | 1.70 [1.29, 2.24] | Subtotal (95% CI) | | 560 | | 545 | 30.30 | 1.56 [1.39, 1.74] | Total events | 362 | | 227 | | | | Heterogeneity: Chi2 = 10.84, df = 13 ; I2 = 0% | Test for overall effect: Z = 7.54 |
| (5) Fire needle therapy + other TCM methods versus phototherapy + same TCM methods | He X. L, 2018 | 26 | 29 | 16 | 28 | 2.20 | 1.57 [1.11, 2.21] | Jing L. H, 2015 | 23 | 31 | 13 | 29 | 1.80 | 1.66 [1.05, 2.61] | Li X. S, 2017 | 34 | 60 | 22 | 60 | 2.90 | 1.55 [1.04, 2.30] | Subtotal (95% CI) | | 120 | | 117 | 6.80 | 1.58 [1.25, 2.00] | Total events | 83 | | 51 | | | | Heterogeneity: Chi2 = 0.05, df = 2 ; I2 = 0% | Test for overall effect: Z = 3.85 |
| (6) Fire needle therapy + other TCM methods versus other traditional treatments | He G, 2018 | 22 | 28 | 16 | 28 | 2.10 | 1.38 [0.95, 2.00] | He G, 2019 | 19 | 35 | 10 | 35 | 1.30 | 1.90 [1.04, 3.48] | Li B, 2018 | 22 | 29 | 12 | 28 | 1.60 | 1.77 [1.10, 2.84] | Liu J. J, 2015 | 22 | 31 | 14 | 29 | 1.90 | 1.47 [0.95, 2.28] | Liu Y, 2019 | 20 | 29 | 13 | 23 | 1.90 | 1.22 [0.79, 1.88] | Wang X, 2016 | 24 | 32 | 13 | 33 | 1.70 | 1.90 [1.19, 3.04] | Zhang J. Y, 2016 | 24 | 32 | 15 | 33 | 2.00 | 1.65 [1.08, 2.52] | Subtotal (95% CI) | | 216 | | 209 | 12.50 | 1.59 [1.34, 1.88] | Total events | 153 | | 93 | | | | Heterogeneity: Chi2 = 3.25, df = 6 ; I2 = 0% | Test for overall effect: Z = 5.27 | Total (95% CI) | | 1688 | | 1650 | 100.00 | 1.55 [1.46, 1.65] | Total events | 1186 | | 747 | | | | Heterogeneity: Chi2 = 34.54, df = 43 ; I2 = 0% | Test for overall effect: Z = 14.34 | Test for subgroup differences: Chi2 = 2.30, df = 5 , I2 = 0% |
| (B) Trials calculating the total effectiveness rate according to the NVSL formula |
| (1) Fire needle therapy + other treatments versus other treatments alone | Cheng K, 2018 | 19 | 38 | 11 | 34 | 6.60 | 1.55 [0.86, 2.76] | Luo G. P, 2016 | 161 | 235 | 118 | 247 | 65.30 | 1.43 [1.23, 1.68] | Xie H. L, 2017 | 64 | 115 | 51 | 122 | 28.10 | 1.33 [1.02, 1.74] | Subtotal (95% CI) | | 388 | | 403 | 100.00 | 1.41 [1.24, 1.61] | Total events | 244 | | 180 | | | | Heterogeneity: Chi2 = 0.32, df = 2 ; I2 = 0% | Test for overall effect: Z = 5.12 |
|
|